Latest Health News from Duke Medicine News and Communications
Search News
For Journalists
Reporters & producers can visit Duke Medicine News and Communications for contact information.
Poliovirus Vaccine Trial Shows Early Promise for Recurrent Glioblastoma
May 21, 2013
An attack on glioblastoma brain tumor cells that uses a modified poliovirus is showing encouraging results in an early study to establish the proper dose level, researchers at Duke Cancer Institute report.
Antidepressant reduces stress-induced heart condition
May 21, 2013
A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.
Doctors should discuss financial concerns of cancer patients
May 16, 2013
Most cancer patients would like to talk about the cost of their care with their doctors, but often don't because they fear the discussion could compromise the quality of their treatment, researchers at Duke Cancer Institute report.
Kernodle Clinic Physicians to Become Part of Duke Medicine’s Faculty Practice Group
May 15, 2013
The physicians of Kernodle Clinic, Inc., one of the Triad region’s premier multi-specialty medical practices, have joined the Private Diagnostic Clinic (PDC), Duke Medicine’s physician practice organization.
Genetic mutation during development causes port-wine stains and Sturge-Weber Syndrome
May 8, 2013
A non-inherited genetic mutation that arises during fetal development has been shown to be the cause of port-wine stains, one of the most common birth defects, as well as a related, but rare disorder called Sturge-Weber Syndrome (SWS).
Duke researchers describe how breast cancer cells acquire drug resistance
May 7, 2013
A seven-year quest to understand how breast cancer cells resist treatment with the targeted therapy lapatinib has revealed a previously unknown molecular network that regulates cell death. The discovery provides new avenues to overcome drug resistance, according to researchers at Duke Cancer Institute.
Competing antibodies may have limited the protection achieved in HIV vaccine trial in Thailand
May 6, 2013
Continuing analysis of an HIV vaccine trial undertaken in Thailand is yielding additional information about how immune responses were triggered and why the vaccine did not protect more people.
Duke researchers identify gene mutations associated with nearsightedness
May 2, 2013
People have long taken for granted that glasses and contact lenses improve vision for nearsightedness, but the genetic factors behind the common condition have remained blurry. Now researchers at Duke Medicine are closer to clearing this up.
Mast cells give clues in diagnosis, treatment of dengue
Apr. 30, 2013
A protein produced by mast cells in the immune system may predict which people infected with dengue virus will develop life-threatening complications, according to researchers at Duke Medicine and Duke-National University of Singapore (Duke-NUS).
Cancer studies often lack necessary rigor to answer key questions
Apr. 29, 2013
Fueled in part by an inclination to speed new treatments to patients, research studies for cancer therapies tend to be smaller and less robust than for other diseases.
May 21, 2013
An attack on glioblastoma brain tumor cells that uses a modified poliovirus is showing encouraging results in an early study to establish the proper dose level, researchers at Duke Cancer Institute report.
Antidepressant reduces stress-induced heart condition
May 21, 2013
A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.
Doctors should discuss financial concerns of cancer patients
May 16, 2013
Most cancer patients would like to talk about the cost of their care with their doctors, but often don't because they fear the discussion could compromise the quality of their treatment, researchers at Duke Cancer Institute report.
Kernodle Clinic Physicians to Become Part of Duke Medicine’s Faculty Practice Group
May 15, 2013
The physicians of Kernodle Clinic, Inc., one of the Triad region’s premier multi-specialty medical practices, have joined the Private Diagnostic Clinic (PDC), Duke Medicine’s physician practice organization.
Genetic mutation during development causes port-wine stains and Sturge-Weber Syndrome
May 8, 2013
A non-inherited genetic mutation that arises during fetal development has been shown to be the cause of port-wine stains, one of the most common birth defects, as well as a related, but rare disorder called Sturge-Weber Syndrome (SWS).
Duke researchers describe how breast cancer cells acquire drug resistance
May 7, 2013
A seven-year quest to understand how breast cancer cells resist treatment with the targeted therapy lapatinib has revealed a previously unknown molecular network that regulates cell death. The discovery provides new avenues to overcome drug resistance, according to researchers at Duke Cancer Institute.
Competing antibodies may have limited the protection achieved in HIV vaccine trial in Thailand
May 6, 2013
Continuing analysis of an HIV vaccine trial undertaken in Thailand is yielding additional information about how immune responses were triggered and why the vaccine did not protect more people.
Duke researchers identify gene mutations associated with nearsightedness
May 2, 2013
People have long taken for granted that glasses and contact lenses improve vision for nearsightedness, but the genetic factors behind the common condition have remained blurry. Now researchers at Duke Medicine are closer to clearing this up.
Mast cells give clues in diagnosis, treatment of dengue
Apr. 30, 2013
A protein produced by mast cells in the immune system may predict which people infected with dengue virus will develop life-threatening complications, according to researchers at Duke Medicine and Duke-National University of Singapore (Duke-NUS).
Cancer studies often lack necessary rigor to answer key questions
Apr. 29, 2013
Fueled in part by an inclination to speed new treatments to patients, research studies for cancer therapies tend to be smaller and less robust than for other diseases.
